Dr. John Kellum, Chief Medical Officer of Spectral, stated, “We view December as a transitional month from an enrollment perspective, as the medical supply chain issues eased. Given the continued ...
The following is a summary of “Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials,” published in the December 2024 issue of ...
Shares of Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report) were up 9.1% during trading on Friday . The company traded as high as $0.38 and last traded at $0.38. Approximately 2,562 shares were ...